Superluminal Medicines, Inc.

Boston, MA · Biotechnology

Superluminal Medicines, Inc. is a biotechnology company based in Boston, Massachusetts. In a Form D filed with the SEC on September 3, 2026, it reported raising $65,480,796 from 16 investors as part of an offering of up to $65,480,796. The first sale in the offering took place on August 10, 2026.

Amount raised: $65,480,796
Offering size: $65,480,796
Investors so far: 16
First sale: August 10, 2026
Securities offered: Equity
Exemption claimed: Rule 506(b)
Industry: Biotechnology
Headquarters: Boston, Massachusetts
Incorporated: Delaware, 2023
Entity type: Corporation

Filings

Filed	Form	Raised	Offering size	Investors	Source
Sep 3, 2026	D (new notice)	$65,480,796	$65,480,796	16	SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Massachusetts

Company	Location	Sector	Raised	Target	Filed
Axelyf, Inc.	Chestnut Hill, MA	Health Care	$2.6M	$2.7M	Oct 13
Soterya, Inc.	Boston, MA	Health Care	$850K	$2M	Oct 13
Bioventrix, Inc.	Mansfield, MA	Health Care	$1.2M	$3M	Oct 8
Opus KSD, Inc.	Pembroke, MA	Health Care	$681K	$681K	Oct 1
Xact Bio, Inc.	Boston, MA	Health Care	$10M	$18M	Sep 28
Way Biosolutions, Inc.	Cambridge, MA	Health Care	$2M	$2M	Sep 25